¹Ì»ý¹° µ¿Á¤ÀÇ ¼¼´ë±³Ã¼ ºü¸£°í °æÁ¦ÀûÀÎ ¹Ì»ý¹° µ¿Á¤ÀÇ Leader - Bruker MALDI Biotyper!!
 
 

Result

Urine, stools, respiratory tract µî human infection¿¡ °üÇÑ ¹Ì»ý¹° 720°³ÀÇ isolates¸¦ ÀÌ¿ëÇÏ¿© ¹Ì»ý¹° µ¿Á¤ ½ÇÇèÀ» ÁøÇàÇÏ¿´´Ù. Figure 2¿¡¼­ Bruker»çÀÇ MS system°ú Shimadzu»çÀÇ MS system ¸ðµÎ¿¡¼­ ´ëºÎºÐÀÇ ¹Ì»ý¹°µéÀÌ Á¤È®È÷ µ¿Á¤ÀÌ µÇ´Â °ÍÀ» È®ÀÎ ÇÒ ¼ö ÀÖ´Ù. Á¤È®ÇÏ°Ô »ìÆì º¸¸é Bruker»çÀÇ MALDI BiotyperÀÇ °æ¿ì 720 isolates Áß¿¡¼­ 680°³ÀÎ 94.4%°¡ high confidence level·Î µ¿Á¤ µÇ¾úÀ¸¸ç Shimadzu»çÀÇ MS systemÀÇ °æ¿ì¿¡´Â 639°³ÀÎ 88.8%°¡ high confidence level·Î µ¿Á¤ÀÌ µÇ¾ú´Ù. (Table 1.)

FIG. 2. Accuracy of MALDI-TOF MS identifications of 720 clinical isolates.
FIG. 2. Accuracy of MALDI-TOF MS identifications
of 720 clinical isolates.

Bruker»ç¿Í Shimadzu»çÀÇ MS system¿¡¼­ high confidence level·Î °¢°¢ ÀÏÄ¡ÇÑ ±ÕÁ¾ 680°³, 639°³ Áß¿¡¼­ ù ¹ø° ºÐ¼®¿¡¼­´Â µ¿Á¤ÀÌ µÇÁö ¾Ê¾ÒÀ¸³ª ÀçºÐ¼®¿¡¼­ high confidence level·Î µ¿Á¤µÈ°á°ú´Â °¢°¢ 39/680(Bruker»ç), 54/639(Shimadzu»ç)·Î È®ÀÎ µÇ¾ú´Ù. Áï, ÃÖÃÊ ½ÇÇè¿¡¼­ high confidence level·Î µ¿Á¤µÈ °á°ú´Â 720°³ÀÇ isolatesÁß¿¡¼­ Bruke»ç´Â 641°³, Shimadzu»ç´Â 585°³ÀÌ´Ù.

TABLE 1. High-confidence identifications
by MALDI-TOF system and taxonomy

TABLE 1. High-confidence identifications by MALDI-TOF system and taxonomy

a n, no. of isolates. b The six incorrect Bruker results were as follows: one isolate identified as Achromobacter xylosoxidans by 16S analysis, not identified by biochemical methods, and identified as Achromobacter denitrificans by MS; one isolate not identified by 16S analysis, identified as Staphylococcus epidermidis by biochemical methods, and identified as Staphylococcus capitis by MS; one isolate identified to the genus level only by 16S analysis, identified as Streptococcus mitis by biochemical methods, and identified as Streptococcus pneumoniae by MS; two isolates identified to the genus level only by 16S analysis, identified as Streptococcus bovis by biochemical methods, and identified as Streptococcus lutiensis by MS; and one isolate identified as Clostridium boltei by 16S analysis, not identified by biochemical methods, and identified as Clostridium casei by MS.
c The three incorrect Shimadzu results were as follows: one isolate identified to the genus level only by 16S, identified as Staphylococcus epidermidis by biochemical methods, and identified ambiguously as Staphylococcus capitis or Staphylococcus caprae by MS; two isolates identified to the genus level only by 16S analysis, as Streptococcus mitis by biochemical methods, and as Streptococcus oralis and Streptococcus pneumoniae by MS. d See footnote b of Table 3.

Table 2´Â phenotypic method¿¡¼­ ¹Ì»ý¹°À» µ¿Á¤Çϴµ¥ »ç¿ëµÇ´Â ºñ¿ë ¹× ½Ã°£À» °è»êÇÑ °á°úÀ̸ç Table 3¿¡¼­´Â Bruker»çÀÇ MALDI-TOF MS systemÀ» ÀÌ¿ëÇÑ ¹Ì»ý¹° µ¿Á¤¿¡¼­ »ç¿ëµÇ´Â ºñ¿ë ¹× ½Ã°£À» ³ªÅ¸³»¾ú´Ù. °á°úÀûÀ¸·Î MALDI-TOF MS systemÀ» ÀÌ¿ëÇÑ ¹Ì»ý¹° µ¿Á¤ÀÌ ±âÁ¸ÀÇ ¹æ¹ý¿¡ ºñÇؼ­ ºñ¿ë ¹× ½Ã°£ÀÌ ¸Å¿ì Àý¾àµÇ´Â °ÍÀ» ¾Ë ¼ö ÀÖ´Ù.

TABLE 2. Cost and timeliness estimates of conventional identification
TABLE 2. Cost and timeliness estimates of conventional identification

TABLE 3. Cost and timeliness estimates of MALDI-TOF MS (Bruker) followed by conventional identificationy
TABLE 3. Cost and timeliness estimates of MALDI-TOF MS (Bruker) followed by conventional identification

Conclusion
º» ¿¬±¸´Â Bruker»ç¿Í Shimadzu»çÀÇ MALDI-TOF MS¸¦ ÀÌ¿ëÇÏ¿© ¹Ì»ý¹° µ¿Á¤À» ½Ç½ÃÇÏ°í ºñ±³ ºÐ¼®ÇÏ¿´À¸¸ç MALDI-TOF¿Í ±âÁ¸ phenotypic method¿ÍÀÇ µ¿Á¤ ºñ¿ë ¹× ½Ã°£À» ºñ±³ÇÏ¿´´Ù.
Bruker»çÀÇ MALDI-TOF MS ½Ã½ºÅÛ¿¡¼­´Â 720°³ÀÇ isolatesÁß¿¡¼­ 680°³(95%)°¡ high confidence·Î µ¿Á¤ÀÌ µÇ¾ú°í Shimadzu»çÀÇ MALDI-TOF MS ½Ã½ºÅÛ¿¡¼­´Â 720°³Áß 639°³(89%)°¡ high confidence level·Î µ¿Á¤ÀÌ µÇ¾ú´Ù.
°á·ÐÀûÀ¸·Î Phenotypic method¿Í PCR¹æ¹ý ´ëºñ MALDI-TOF MS systemÀ» ÀÌ¿ëÇÑ ¹Ì»ý¹° µ¿Á¤¹ýÀº ºñ¿ë ¹× ½Ã°£ Àý¾à Ãø¸é¿¡¼­ ¸Å¿ì È¿À²ÀûÀÎ ÀåºñÀÌ´Ù.